400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / JAK/STAT Signaling / JAK / Momelotinib Mesylate
CAS No.: 1056636-07-7
Synonyms: CYT387 Mesylate
CYT387 mesylate is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, ~10-fold selectivity versus JAK3.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02251821 | Primary Myelofibrosis ... more >> Secondary Myelofibrosis Collapse << | Phase 2 | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit 206-667-1317 rsalit@fredhutch.org Principal Investigator: Rachel B. Salit Collapse << |
实验方案
技术信息
CAS号 | 1056636-07-7 | 储存条件 |
|
|
分子式 | C24H26N6O5S | 运输 | 蓝冰 | |
分子量 | 510.57 | 别名 | CYT387 Mesylate |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02251821 | Primary Myelofibrosis ... more >> Secondary Myelofibrosis Collapse << | Phase 2 | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit 206-667-1317 rsalit@fredhutch.org Principal Investigator: Rachel B. Salit Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网